Boston Scientific (BSX) PT Raised to $92 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $45.82 --0%
Rating Summary:
28 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 2
Rating Summary:
28 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 2
Join SI Premium – FREE
Morgan Stanley analyst Patrick Wood raised the price target on Boston Scientific (NYSE: BSX) to $92.00 (from $79.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Increasing unusual call option volume: BSX SGHC USAS SYF INO CHGG EVGO REAL ITB MNRO KMX MSOS SGI PGY HNST GMAB
- SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints
- BB Seguridade (BBSE3:BZ) (BBSEY) PT Lowered to BRL33 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
